Aspiriant Real Assets Fund has announced a tender offer to purchase shares worth approximately $9.8 million, representing about 5% of its net assets. This strategic move is designed to enhance shareholder value and reflects the company's ongoing commitment to its investors. The tender offer will allow shareholders to sell their shares at the net asset value (NAV), calculated as of December 31, 2026.

The offer is significant as it comes at a time when investment funds are increasingly looking for ways to return value to their shareholders. By offering to buy back shares, Aspiriant aims to provide liquidity to its investors while also potentially improving the overall value of remaining shares.

Background

Aspiriant Real Assets Fund, registered as a closed-end, non-diversified management investment company under the Investment Company Act of 1940, operates out of Milwaukee, Wisconsin. The fund has undergone several name changes in recent years, previously known as Aspiriant Risk-Managed Real Assets Fund. As of June 30, 2026, the fund had approximately 17.4 million shares outstanding.

What the Filing Says

According to the SEC filing dated October 27, 2026, the fund is offering to purchase up to approximately 871,763 shares at their NAV. The NAV per share was calculated at $11.26 as of June 30, 2026. Shareholders wishing to tender their shares must do so by December 17, 2026, with the possibility of extending the offer at the discretion of the fund's Board of Trustees.

Impact

This tender offer may primarily affect the shareholders of Aspiriant Real Assets Fund, providing them with an opportunity to liquidate their investments at a favorable price. Additionally, this move could set a precedent for other funds in the industry, prompting them to consider similar strategies to enhance shareholder value.

What's Next

The filing does not specify what happens next beyond the tender offer deadline. Shareholders are encouraged to participate before the December 17, 2026, deadline to take advantage of this opportunity.